Insight Molecular Diagnostics Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Insight Molecular Diagnostics Inc. (IMDX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 88.92 thousand shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-11
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was -263.08M shares.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 91.45M shares, a 36.00% increase year-over-year.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 89.76M shares, a 36.34% increase year-over-year.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 82.12M shares, a 33.62% increase year-over-year.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 88.92K shares, a 35.80% increase from fiscal 2020.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 65.48K shares, a 99.87% decline from fiscal 2019.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 51.30M shares, a 35.52% increase from fiscal 2018.
- Insight Molecular Diagnostics Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 37.85M shares, a 25.35% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -263.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -85.81M shares derived: average of 2 quarters · filed 2022-03-11 | -27.29M shares derived: average of 3 quarters · filed 2022-03-11 | 88.92K shares 10-K · filed 2022-03-11 | ||||
| 2021-09-30 | 91.45M shares 10-Q · filed 2021-11-09 | 90.61M shares derived: average of 2 quarters · filed 2021-11-09 | 87.81M shares 10-Q · filed 2021-11-09 | 17.27M shares derived: average of 4 quarters · filed 2022-03-11 | ||||
| 2021-06-30 | 89.76M shares 10-Q · filed 2021-08-11 | 85.96M shares 10-Q · filed 2021-08-11 | -7.46M shares derived: average of 3 quarters · filed 2022-03-11 | 11.22M shares derived: average of 4 quarters · filed 2022-03-11 | ||||
| 2021-03-31 | 82.12M shares 10-Q · filed 2021-05-17 | -56.07M shares derived: average of 2 quarters · filed 2022-03-11 | -14.97M shares derived: average of 3 quarters · filed 2022-03-11 | 5.23M shares derived: average of 4 quarters · filed 2022-03-11 | ||||
| 2020-12-31 | -194.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -63.51M shares derived: average of 2 quarters · filed 2022-03-11 | -20.40M shares derived: average of 3 quarters · filed 2022-03-11 | 65.48K shares 10-K · filed 2022-03-11 | 65.48M shares 10-K · filed 2021-03-19 | |||
| 2020-09-30 | 67.25M shares 10-Q · filed 2021-11-09 | 67.25K shares 10-Q · filed 2020-11-12 | 66.54M shares derived: average of 2 quarters · filed 2021-11-09 | 64.84M shares 10-Q · filed 2021-11-09 | 64.84K shares 10-Q · filed 2020-11-12 | 99.89M shares derived: average of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | 65.83M shares 10-Q · filed 2021-08-11 | 65.83K shares 10-Q · filed 2020-07-29 | 63.63M shares 10-Q · filed 2021-08-11 | 63.63K shares 10-Q · filed 2020-07-29 | 110.78M shares derived: average of 3 quarters · filed 2021-08-11 | 83.09M shares derived: average of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | 61.46M shares 10-Q · filed 2021-05-17 | 61.46K shares 10-Q · filed 2020-05-12 | 133.25M shares derived: average of 2 quarters · filed 2021-05-17 | 88.85M shares derived: average of 3 quarters · filed 2021-05-17 | 66.65M shares derived: average of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | 205.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | 102.54M shares derived: average of 2 quarters · filed 2021-03-19 | 68.38M shares derived: average of 3 quarters · filed 2021-03-19 | 51.30M shares 10-K · filed 2021-03-19 | ||||
| 2019-09-30 | 51.97K shares 10-Q · filed 2020-11-12 | 51.97M shares 10-Q · filed 2019-11-14 | 51.97K shares derived: average of 2 quarters · filed 2020-11-12 | 50.22K shares 10-Q · filed 2020-11-12 | 50.22M shares 10-Q · filed 2019-11-14 | 10.21M shares derived: average of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | 51.97K shares 10-Q · filed 2020-07-29 | 51.97M shares 10-Q · filed 2019-08-14 | 49.32K shares 10-Q · filed 2020-07-29 | 49.32M shares 10-Q · filed 2019-08-14 | 13.60M shares derived: average of 3 quarters · filed 2020-07-29 | 20.26M shares derived: average of 4 quarters · filed 2020-07-29 | ||
| 2019-03-31 | 46.65K shares 10-Q · filed 2020-05-12 | 46.65M shares 10-Q · filed 2019-05-14 | 20.37M shares derived: average of 2 quarters · filed 2020-05-12 | 26.99M shares derived: average of 3 quarters · filed 2020-05-12 | 29.92M shares derived: average of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | 40.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 40.46M shares derived: average of 2 quarters · filed 2020-03-26 | 39.88M shares derived: average of 3 quarters · filed 2020-03-26 | 37.85M shares 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | 40.23M shares 10-Q · filed 2019-11-14 | 40.23K shares 10-Q · filed 2018-11-13 | 39.47M shares derived: average of 2 quarters · filed 2019-11-14 | 36.90M shares 10-Q · filed 2019-11-14 | 36.90K shares 10-Q · filed 2018-11-13 | 57.83M shares derived: average of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | 38.71M shares 10-Q · filed 2019-08-14 | 35.21M shares 10-Q · filed 2019-08-14 | 63.69M shares derived: average of 3 quarters · filed 2019-08-14 | 47.78M shares derived: average of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | 31.68M shares 10-Q · filed 2019-05-14 | 76.18M shares derived: average of 2 quarters · filed 2019-05-14 | 50.80M shares derived: average of 3 quarters · filed 2019-05-14 | 45.45M shares derived: average of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | 120.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | 60.36M shares derived: average of 2 quarters · filed 2019-04-01 | 50.04M shares derived: average of 3 quarters · filed 2019-04-01 | 30.20M shares 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | 30.94K shares 10-Q · filed 2018-11-13 | 30.94M shares 10-Q · filed 2017-11-14 | 14.71M shares derived: average of 2 quarters · filed 2018-11-13 | 29.77K shares 10-Q · filed 2018-11-13 | 29.77M shares 10-Q · filed 2017-11-14 | 21.78M shares derived: average of 4 quarters · filed 2018-11-13 | ||
| 2017-06-30 | 29.40M shares 10-Q · filed 2018-08-14 | 29.18M shares 10-Q · filed 2018-08-14 | 29.03M shares derived: average of 3 quarters · filed 2018-08-14 | 28.41M shares derived: average of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | 28.96M shares 10-Q · filed 2018-05-15 | 28.84M shares derived: average of 2 quarters · filed 2018-05-15 | 28.08M shares derived: average of 3 quarters · filed 2018-05-15 | 27.42M shares derived: average of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | 28.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 27.64M shares derived: average of 2 quarters · filed 2018-04-02 | 26.90M shares derived: average of 3 quarters · filed 2018-04-02 | 26.53M shares 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | 26.56M shares 10-Q · filed 2017-11-14 | 25.99M shares derived: average of 2 quarters · filed 2017-11-14 | 25.80M shares 10-Q · filed 2017-11-14 | 25.50M shares derived: average of 4 quarters · filed 2018-04-02 | ||||
| 2016-06-30 | 25.43M shares 10-Q · filed 2017-08-14 | 25.41M shares 10-Q · filed 2017-08-14 | 25.15M shares derived: average of 3 quarters · filed 2018-04-02 | 24.11M shares derived: average of 4 quarters · filed 2018-04-02 | ||||
| 2016-03-31 | 25.40M shares 10-Q · filed 2017-04-28 | 25.01M shares derived: average of 2 quarters · filed 2018-04-02 | 23.66M shares derived: average of 3 quarters · filed 2018-04-02 | 23.05M shares derived: average of 4 quarters · filed 2018-04-02 | ||||
| 2015-12-31 | 24.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 22.80M shares derived: average of 2 quarters · filed 2018-04-02 | 22.27M shares derived: average of 3 quarters · filed 2018-04-02 | 21.01M shares 10-K · filed 2018-04-02 | ||||
| 2015-09-30 | 20.97M shares 10-Q · filed 2016-11-10 | 21.09M shares derived: average of 2 quarters · filed 2016-11-10 | 19.80M shares 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | 21.20M shares 10-Q · filed 2016-08-11 | 21.20M shares 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | 18.20M shares 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | 18.20M shares 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |